Skip to content
Recall Observatory FDA recall evidence

Drug product

Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90

D-0559-2023

April 06, 2023

Class II

Product summary

Firm
PD-Rx Pharmaceuticals, Inc.
Event
Event 92081
Status
Terminated
Classification
Class II
Quantity
186 bottles
Official record key
drug-enforcement:D-0559-2023

Official wording

Reason: CGMP deviations.

Code information: Lots: A22B45 Exp. 01/31/24; C22A73, E22E41, C22D28, F22B68, G22A29, H22B97, K22A36 Exp. 03/31/24; K22B99, A23D07, B23B25 Exp. 10/31/24; B23B55 Exp. 06/30/25

Distribution pattern: Nationwide in the US.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP deviations